November 12, 2014Open Access

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Ketamine may be considered a valid and intriguing antidepressant option for the treatment of TRD. Further studies are needed to evaluate its long-term antidepressant efficacy in patients with TRD.

Me gusta

Guardar

Ver artículo completo

Cite This Study

Serafini et al. (Wed,) studied this question.

synapsesocial.com/papers/69d8a2d5183921ebcaae3094 https://doi.org/https://doi.org/10.2174/1570159x12666140619204251

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?2013 · 28 citations
2The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration2009 · 3,454 citations
3Yaşlı Kadınlarda Üreme Sağlığı169,601 citations
4The role of microRNAs in synaptic plasticity, major affective disorders and suicidal behavior2012 · 81 citations
5Enhanced anxiety, depressive‐like behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1)2007 · 164 citations

Me gusta

Guardar

Ver artículo completo